AZD4635 Relative Bioavailability Study

Condition:   Healthy Volunteers Interventions:   Drug: AZD4635 50 mg nano-suspension (reference);   Drug: AZD4635 solid oral formulation - fasted;   Drug: AZD4635 solid oral formulation - fed;   Drug: Lansoprazole and AZD4635 50 mg solid oral formulation;   Drug: AZD4635 solid oral formulation variant 1 - fasted;   Drug: AZD4635 solid oral formulation variant 2 - fasted;   Drug: [14C] AZD4635 IV microtracer - fasted Sponsors:   AstraZeneca;   Quotient Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials